| Medicinal product name | Escitalopram Actavis 10 mg film-coated tablets |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Film-coated tablet | ||||||
| Strength | 10 mg | ||||||
| Information from the MAH on shortages | No information on expected shortages | ||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.) Reimbursed medicines reference product |
||||||
| Package leaflet |  17-08-2023
|
||||||
| Summary of product characteristics | 17-08-2023
|
||||||
| ATC code | N06AB10 – Psychoanaleptics | ||||||
| Information for Marketing authorisation holders | View |
Medicinal products (12)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (10 mg) |
PVC/PVDC/Al blister | 09-0497-01 |
 Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (10 mg) |
PVC/PVDC/Al blister | 09-0497-02 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
|
Is available (according to the information provided by wholesalers) (2283 containers) |
Tamro, Magnum Medical, Jelgavfarm, Euroaptieka, Medelens+ |
N28 (10 mg) |
PVC/PVDC/Al blister |
€ 3.35 * |
09-0497-03 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (10 mg) |
PVC/PVDC/Al blister | 09-0497-04 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (10 mg) |
PVC/PVDC/Al blister | 09-0497-05 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (10 mg) |
PVC/PVDC/Al blister | 09-0497-06 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (10 mg) |
PVC/PVDC/Al blister | 09-0497-07 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (10 mg) |
PVC/PVDC/Al blister | 09-0497-08 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (10 mg) |
PVC/PVDC/Al blister | 09-0497-09 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N200 (10 mg) |
PVC/PVDC/Al blister | 09-0497-10 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (10 mg) |
HDPE bottle | 09-0497-11 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N200 (10 mg) |
HDPE bottle | 09-0497-12 |
Labelling text Aug 17, 2023 Labelling text Aug 17, 2023 |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Registration information
| Marketing authorisation No. | 09-0497 |
|---|---|
| Date of authorisation | Dec 21, 2009 |
| Marketing authorisation holder, country | Teva B.V., Netherlands |
